Blood-Based Biomarkers for Alzheimer Disease-Ready for Primary Care?

Lawren VandeVrede¹, Gil D Rabinovici^{1

2

3}

Affiliations

¹ Memory & Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, California.
² Department of Radiology & Biomedical Imaging, University of California, San Francisco, San Francisco, California.
³ Associate Editor, JAMA Neurology.

Lawren VandeVrede et al. JAMA Neurol. 2024.

. 2024 Oct 1;81(10):1030-1031.

doi: 10.1001/jamaneurol.2024.2801.

Lawren VandeVrede¹, Gil D Rabinovici^{1

2

3}

¹ Memory & Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, California.
² Department of Radiology & Biomedical Imaging, University of California, San Francisco, San Francisco, California.
³ Associate Editor, JAMA Neurology.

No abstract available

Comment in

Changes in Alzheimer Disease Blood Biomarkers and Associations With Incident All-Cause Dementia.
Lu Y, Pike JR, Chen J, Walker KA, Sullivan KJ, Thyagarajan B, Mielke MM, Lutsey PL, Knopman D, Gottesman RF, Sharrett AR, Coresh J, Mosley TH, Palta P. Lu Y, et al. JAMA. 2024 Oct 15;332(15):1258-1269. doi: 10.1001/jama.2024.6619. JAMA. 2024. PMID: 39068543 Free PMC article.
Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care.
Palmqvist S, Tideman P, Mattsson-Carlgren N, Schindler SE, Smith R, Ossenkoppele R, Calling S, West T, Monane M, Verghese PB, Braunstein JB, Blennow K, Janelidze S, Stomrud E, Salvadó G, Hansson O. Palmqvist S, et al. JAMA. 2024 Oct 15;332(15):1245-1257. doi: 10.1001/jama.2024.13855. JAMA. 2024. PMID: 39068545 Free PMC article.